Boothbay Fund Management, LLC Orchard Therapeutics PLC Transaction History

Boothbay Fund Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.42 - $0.78 $6,271 - $11,646	-14,932 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.23 $53,571 - $102,985	-46,182 Reduced 75.57%	14,932 $20,000
Q3 2021 Nov 15, 2021	BUY	$2.24 - $4.29 $31,897 - $61,089	14,240 Added 30.38%	61,114 $141,000
Q2 2021 Aug 16, 2021	SELL	$4.39 - $7.23 $27,231 - $44,847	-6,203 Reduced 11.69%	46,874 $206,000
Q1 2021 May 17, 2021	BUY	$4.39 - $9.08 $116,870 - $241,727	26,622 Added 100.63%	53,077 $385,000
Q4 2020 Feb 12, 2021	BUY	$3.86 - $5.07 $102,116 - $134,126	26,455 New	26,455 $114,000
Q4 2019 Feb 14, 2020	SELL	$10.15 - $15.58 $515,620 - $791,464	-50,800 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$11.88 - $16.72 $603,504 - $849,376	50,800 New	50,800 $604,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.